US Bancorp
JUNO

US Bancorp’s Juno Therapeutics, Inc. JUNO Stock Holding History

US Bancorp’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-87,398
Closed -$3.99M – 3787
2017
Q4 		$3.99M Buy
87,398
+133
+0.2% +$6.63K 0.01% 561
2017
Q3 		$3.91M Buy
87,265
+265
+0.3% +$9.04K 0.01% 547
2017
Q2 		$2.6M Sell
87,000
-7,100
-8% -$175K 0.01% 671
2017
Q1 		$2.09M Hold
94,100
– – 0.01% 765
2016
Q4 		$1.77M Buy
94,100
+3,200
+4% +$78.3K 0.01% 802
2016
Q3 		$2.73M Hold
90,900
– – 0.01% 625
2016
Q2 		$3.49M Buy
90,900
+200
+0.2% +$8.3K 0.01% 530
2016
Q1 		$3.46M Buy
90,700
+2,000
+2% +$69.7K 0.01% 533
2015
Q4 		$3.9M Buy
88,700
+1,600
+2% +$79.4K 0.02% 501
2015
Q3 		$3.54M Buy
87,100
+76,000
+685% +$3.33M 0.01% 525
2015
Q2 		$592K Buy
11,100
+100
+0.9% +$5.31K ﹤0.01% 1271
2015
Q1 		$667K Buy
+11,000
New +$534K ﹤0.01% 1217

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

US Bancorp's JUNO Position: Q1 2018 in Review

US Bancorp sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 87,398 shares — an estimated $3.99M sold.

US Bancorp first reported a position in JUNO in Q1 2015 and held it in 12 quarters. The position peaked at $3.99M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • US Bancorp reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • US Bancorp sold 87,398 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $3.99M.
  • US Bancorp first reported a position in Juno Therapeutics, Inc. in Q1 2015 and held it in 12 quarters.
  • US Bancorp's Juno Therapeutics, Inc. position peaked at $3.99M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on US Bancorp's 13F filing for Q1 2018, filed 8 May 2018.